The University of Rochester, a national leader in rare diseases clinical research and therapeutic development, will host a day-long symposium on novel applications of technology to accelerate the development of new therapeutics for patients with rare neurological disorders.
Attendees will learn from a cadre of industry leaders in rare diseases, health technologies and clinical trials as they demonstrate how to:
- leverage new tools and technologies to enhance patient partnership
- reduce the burden of participation in clinical research
- accelerate development of new therapeutics